Search: Empty
HD Buzz on MSH3, HDSA COEs, Research Study
by Kelly Andrew
Somatic Instability: HD Buzz reports what’s with all the hype about MSH3 A group of scientists at UMass Chan Medical…
Genetic Modifiers, CSF Flow, and Sleep in HD
by Kelly Andrew
HD Buzz on Genetic Modifiers in HD People with an expanded section of CAG repeats in a copy their huntingtin…
Valbenazine Approved, HD History, Gene therapy success
by Kelly Andrew
FDA approves Valbenazine to treat HD chorea Last week, on August 18th, Neurocrine Biosciences shared that the FDA has approved…
Research Webinar, Renewing HD brain cells, HD History
by Kelly Andrew
HDSA Research Webinar: Leaving a Legacy, Brain Donation for HD Research Brain donation is an invaluable gift that makes a…
Clinical Research Updates, CHDI Therapeutics Conference, Up & Coming HD Scientists
by Kelly Andrew
Clinical Trials News: positive updates from uniQure and PTC Therapeutics This week, we had two updates from major players…
HD Research Webinar, HD Awareness, & Youth Research
by Kelly Andrew
HDSA & HSC Research Webinar TOMORROW Tomorrow at 1PM ET, HDSA and the Huntington’s Society of Canada (HSC) will co-host…
CHDI Therapeutics Conference: Prilenia shares data from the PROOF-HD trial
by Kelly Andrew
CHDI Therapeutics Conference: Prilenia shares data from the PROOF-HD trial The CHDI Therapeutics conference is ongoing this week in Dubrovnik,…
Thank you Volunteers, Buzz on brain cells, Next Week in HD
by Kelly Andrew
Thank you, HD Research Volunteers! This week, HDSA is celebrating National Volunteer Appreciation Week. This goes for research, too! We’d…
HD Buzz on the Brain, Vico begins dosing, New Podcast
by Kelly Andrew
How does an HD brain find balance? HD Buzz covers the latest clues It is well known that Huntington’s disease…
HDSA Centers of Excellence, Research Webinar, GENERATION HD2
by Kelly Andrew
HDSA Names 56 Centers of Excellence and 11 Partner Sites in 2023 This week, HDSA announced its Center of…
HDBuzz, STAT News, Ask the Scientists, & More
by admin
HDBuzz Covers Latest Update from Novartis Last week, Novartis shared that they will end development of branaplam for HD. Dosing of…
HDBuzz on Novartis, HDSA Research Webinar, STAT News on HD Research, Online Survey
by Kelly Andrew
HDBuzz Covers Latest Update from Novartis Last week, Novartis shared that they will end development of branaplam for HD….
HDSA Research Awards, Clinical Trials Updates & HD Podcasts
by Kelly Andrew
HDSA Awards Six Huntington’s Disease Human Biology Project Research Fellowships for 2022 After thoughtful deliberation by its Scientific Advisory Board,…
This Week’s Blog: 10.6.2022
by Kelly Andrew
HDBuzz on ASO headlines: What’s the latest on huntingtin-lowering? Recent weeks have brought news for familiar players in the…
HDSA Research Webinar Recording: All you need to know about PROOF-HD
by admin
This week HDSA hosted a research webinar in which Dr. Michael Hayden, CEO of Prilenia, and clinical leads Drs. Andy…
HDSA webinar Sept 7th: All you Need to Know About PROOF-HD
by admin
In its Phase III trial, PROOF-HD, Prilenia is currently studying the effects of pridopidine on total functional capacity in people with HD. On…
#LetsTalkAboutHD Clinical Trials
by admin
Multiple pieces of news about ongoing clinical trials were shared this week by companies developing therapies for HD. We discuss…
HDSA Statement Regarding VIBRANT-HD Trial
by admin
Novartis shares disappointing update from the VIBRANT-HD trial of branaplam This afternoon, Novartis shared with HD community organizations that dosing…
Unpacking uniQure’s safety data: HDBuzz breaks down AMT-130 updates
by admin
Two weeks ago, uniQure released a safety update for the first 10 participants in the low-dose cohort of the phase I/II trial…
uniQure announces positive safety data in study of AMT-130
by admin
uniQure announces positive safety data in study of AMT-130 uniQure released a safety update this morning for the first 10 participants…
